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Liver Intensive Therapy Unit, Institute of Liver Studies, Kings College Hospital, Denmark Hill, London SE5 9RS, UKIdentifying patients with acute liver failure (ALF) who will
beneﬁt from emergency liver transplantation (ELT) is not
straightforward. Inaccurate selection carries major consequences.
A patient who would have survived with medical management,
incorrectly identiﬁed and transplanted will be subjected to
unnecessary surgery, life-long immuno-suppression, and an
increased risk of death. Additionally, a graft that could be utilised
in another more appropriate candidate will be lost. The conse-
quences of failure to identify a patient with ALF who would sur-
vive only with ELT are of equal magnitude as a potentially
preventable death will result.
The transplantation selection criteria developed at Kings Col-
lege Hospital (the KCC) are amongst the most commonly used,
forming the basis for ELT registration in the United Kingdom
and are in widespread international use [1,2]. Whilst their spec-
iﬁcity is consistently reported to be at a high and clinically
acceptable level, case series and meta-analysis suggest that sen-
sitivity and negative predictive value are limited and may fail to
identify a signiﬁcant proportion of patients who will not survive
without transplantation [3,4]. Furthermore, potential ELT recipi-
ents may be identiﬁed relatively late in their disease course such
that the ‘window of opportunity’ for successful surgery is very
short [5]. There is, thus, a need for supplemental early markers
of poor prognosis to enhance the performance of the KCC, ideally
being determined rapidly and easily with inclusion maintaining
speciﬁcity and clinical simplicity but increasing sensitivity.
Arterial blood lactate measurement has many of these ideal
features. It can be measured rapidly and accurately by point-of-
care testing, and in the critically ill levels closely relates to sever-
ity of multiple organ failure. High arterial concentrations are
near-universally associated with a poor prognosis [6]. In ALF,
arterial blood lactate levels reﬂect both increased production
from peripheral tissues and the injured liver and reduced clear-
ance from the circulation as a consequence of impaired hepatic
metabolic capacity. In this setting hyperlactataemia may indicate
the severity of both the hepatic injury sustained and the accom-
panying multiple organ failure [7].
These features make lactate measurement particularly attrac-
tive as a selection criterion in paracetamol-induced ALF, where
the duration of illness is short and multi-organ failure dominatesJournal of Hepatology 20
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Kings College criteria.the clinical course [8]. In a mixed prospective/retrospective study
of over 200 patients with paracetamol-induced ALF we found
high blood lactate levels to be closely related to a fatal outcome.
We suggested that the inclusion of speciﬁc threshold values into
the KCC might improve test performance, increasing the speed of
ELT candidate selection and sensitivity without a deleterious
reduction in speciﬁcity [7].
Incorporation into decision-making protocols is of course
dependent upon the results of external validation studies. A num-
ber have examined arterial blood lactate in ALF, ﬁnding high lev-
els to be associated strongly and independently with death or
transplantation in both paracetamol and non-paracetamol-
induced disease [9–12]. Analysis of the performance of inclusion
of the speciﬁc thresholds into the KCC for paracetamol-induced
disease has been less consistent, with a report suggesting that
early levels resulted in an increase in sensitivity in identifying
non-survivors but at the expense of a critical reduction in speci-
ﬁcity [10]. However, two other independent studies found that
lactate measurements alone 12 h after admission to transplant
centres had high predictive accuracy, with performance greater
than the KCC alone [11,12].
Several factors may underly these observations, but of likely
central importance is variability in the timing and degree of ﬂuid
resuscitation used to correct hypovolaemia at different centres.
Improvements in systemic circulatory perfusion follow restora-
tion of circulating volume. Clinical experience has shown that
in parallel, substantial initial elevations in blood lactate may also
correct rapidly. Persistent hyperlacatatemia has consistently
been shown to be of grave prognostic signiﬁcance, emphasising
the importance of serial monitoring [7,11].
What is the current place of blood lactate measurement in
selection of potential transplant candidates? Decision-making
on the basis of a single level at one point in time is not appropri-
ate [8]. Whilst early blood lactate measurement provides a rapid
initial indicator of the severity of disease and permits gross risk
stratiﬁcation, the greatest prognostic value will be gained from
those patients in whom no correction of initially high levels
occurs following volume resuscitation. In paracetamol-induced
disease and in the context of coagulopathy and encephalopathy
from acute liver injury, a sustained elevation of blood lactate
should trigger consideration for transplant listing.
As ever, clinical judgement remains the key to listing deci-
sions by the transplant team. Along with the psychosocial factors
that must be considered, the decision-making process is a
dynamic one that includes the continuous assessment of multiple
clinical parameters [8,13]. Blood lactate measurement forms one
useful component of the overall assessment of the patient with10 vol. 53 j 209–210
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ALF and assists decision-making in relation to expected
prognosis.Conﬂicts of interest
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